Related Experiment Video
Updated: May 29, 2026

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation
Published on: December 5, 2025
CO(2) inhalation as a treatment for apnea of prematurity: a randomized double-blind controlled trial
Ruben E Alvaro1, Mohammad Khalil, Mansour Qurashi
1Department of Pediatrics, University of Manitoba, Winnipeg, Manitoba, Canada. ralvaro@exchange.hsc.mb.ca
Insights
Theophylline effectively reduced apnea in premature infants, while inhaled carbon dioxide (CO2) was less effective and led to treatment failures. Theophylline remains the preferred treatment for apnea of prematurity.
Area of Science:
- Neonatal Medicine
- Respiratory Physiology
- Pharmacology
Background:
- Apnea of prematurity is a common respiratory challenge in preterm infants.
- Theophylline is a standard treatment, but alternative therapies are being explored.
Purpose of the Study:
- To compare the efficacy of theophylline with low-concentration inhaled carbon dioxide (CO2) for treating apnea of prematurity.
Main Methods:
- A prospective, randomized, double-blind controlled trial involving 87 preterm infants.
- Infants received either theophylline or placebo with inhaled CO2 via nasal prongs for 3 days.
Main Results:
- Theophylline significantly reduced apnea time compared to baseline and CO2.
- Inhaled CO2 showed a less pronounced reduction in apnea time.
- Seven infants in the CO2 group discontinued treatment due to severe apnea, versus none in the theophylline group.
Conclusions:
- Theophylline is more effective than low-concentration inhaled CO2 for managing apnea of prematurity.
- Inhaled CO2, as administered in this study, is not a viable alternative to theophylline.
- Variability in CO2 delivery may have contributed to its reduced efficacy.
Objective:
To compare the effect of prolonged inhalation of a low concentration of CO(2) with theophylline for the treatment of apnea of prematurity.
Study Design:
Prospective, randomized, double-blind controlled trial of 87 preterm infants with apnea of prematurity (27-32 weeks' gestational age) assigned to either theophylline plus 0.5 L/min of room air via nasal prongs or placebo plus 0.5 L/min with CO(2) (about 1% inhaled) by nasal prongs for 3 days.
Results:
Apnea time significantly decreased in the theophylline group from 189±33 s/h (control) to 57±11, 50±9, and 61±13 (days 1-3) (P=.0001) and in the CO(2) group from 183±44 (control) to 101±26, 105±29, and 94±26 s/h (days 1-3) (P=.03). Seven infants in the CO(2) group but none in the theophylline group failed to complete the study due to severe apneas (P=.003).
Conclusions:
Because theophylline was more effective in reducing the number and severity of apneas, inhalation of low concentration of CO(2), as used in the present study, cannot be considered as an alternative to theophylline in the treatment of apnea of prematurity. The less effectiveness of CO(2) treatment may have been related to the variability of the delivery of CO(2).
More Related Videos
Related Concept Videos
Cardiopulmonary Resuscitation II: ACLS Airway Management
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Physiological Control of Respiration
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Sleep Apnea
The condition is more prevalent among...
